Does ELACESTRANT Cause Product dose omission issue? 364 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 364 reports of Product dose omission issue have been filed in association with ELACESTRANT (ORSERDU). This represents 5.3% of all adverse event reports for ELACESTRANT.
364
Reports of Product dose omission issue with ELACESTRANT
5.3%
of all ELACESTRANT reports
9
Deaths
102
Hospitalizations
How Dangerous Is Product dose omission issue From ELACESTRANT?
Of the 364 reports, 9 (2.5%) resulted in death, 102 (28.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELACESTRANT. However, 364 reports have been filed with the FAERS database.
What Other Side Effects Does ELACESTRANT Cause?
Nausea (1,454)
Fatigue (1,081)
Disease progression (777)
Vomiting (662)
Diarrhoea (540)
Death (499)
Drug ineffective (478)
Constipation (389)
Decreased appetite (363)
Pain (361)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ELACESTRANT Alternatives Have Lower Product dose omission issue Risk?
ELACESTRANT vs ELAFIBRANOR
ELACESTRANT vs ELAGOLIX
ELACESTRANT vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
ELACESTRANT vs ELAPEGADEMASE-LVLR
ELACESTRANT vs ELASOMERAN